Universal reference book for medicines
Product name: TAURIN-AKOS (TAURINE-AKOS)

Active substance: taurine

Type: A drug that stimulates regeneration processes for topical application in ophthalmology

Manufacturer: SYNTHESIS (Russia)
Composition, form of production and packaging
Eye drops 4%
colorless, transparent.

1 ml

taurine 40 mg

[PRING] methyl parahydroxybenzoate (nipagine, methylparaben), water d / u.

5 ml - a bottle-droppers polymer (1) - packs cardboard.

10 ml - a bottle-droppers polymer (1) - packs cardboard.

INSTRUCTION FOR THE SPECIALIST.

The product description was approved by the manufacturer for the 2009 print edition.

PHARMACHOLOGIC EFFECT

An anticancer agent, it has a metabolic effect.

Taurine is a sulfur-containing amino acid that forms in the body during the conversion of cysteine.
Stimulates the processes of repair and regeneration in diseases of a dystrophic nature and diseases accompanied by a sharp disruption of the metabolism of the eye tissues.
It promotes the normalization of the functions of cell membranes, activation of energy and metabolic processes, preservation of the electrolyte composition of the cytoplasm due to the accumulation of potassium and calcium ions, and improvement of the conditions for conduction of a nerve impulse.

PHARMACOKINETICS

With topical application, systemic absorption is low.

INDICATIONS

- corneal dystrophy;

- senile, diabetic, traumatic and radiation cataracts;

- trauma of the cornea (as a stimulant of reparative processes).

DOSING MODE

When cataracts are prescribed in the form of instillations 1-2 drops 2-4 times / day for 3 months.
The course is repeated at a monthly interval.
In injuries and dystrophic diseases, corneas are used in the same doses for 1 month.

SIDE EFFECT

Allergic reactions.

CONTRAINDICATIONS

- Children's age (up to 18 years);

- Hypersensitivity.

PREGNANCY AND LACTATION

The use of the drug during pregnancy and during lactation is possible only after the ratio of risk / benefit (efficacy and safety not established).

APPLICATION FOR CHILDREN

The efficacy and safety of the drug in patients under the age of 18 years is not established.

SPECIAL INSTRUCTIONS

The efficacy and safety of the drug in patients under the age of 18 years is not established.

TERMS OF RELEASE FROM PHARMACY

The drug is released by prescription.

TERMS AND CONDITIONS OF STORAGE

List B. Keep out of reach of children, protected from light, at a temperature of 8 ° to 15 ° C.
Shelf life - 3 years.
After opening the vial, use within 1 month.

Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!